IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
